Related references
Note: Only part of the references are listed.Biomarkers of Cerebral Injury and Inflammation in Pediatric Tuberculous Meningitis
Ursula K. Rohlwink et al.
CLINICAL INFECTIOUS DISEASES (2017)
Title: role of matrix metalloproteinase-9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease
S. Majeed et al.
BMC INFECTIOUS DISEASES (2016)
Value of different staging systems for predicting neurological outcome in childhood tuberculous meningitis
R. van Toorn et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Metzincin Proteases and Their Inhibitors: Foes or Friends in Nervous System Physiology?
Santiago Rivera et al.
JOURNAL OF NEUROSCIENCE (2010)
Tuberculous meningitis: a uniform case definition for use in clinical research
Suzaan Marais et al.
LANCET INFECTIOUS DISEASES (2010)
DIVERSE ROLES OF MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF METALLOPROTEINASES IN NEUROINFLAMMATION AND CEREBRAL ISCHEMIA
E. Candelario-Jalil et al.
NEUROSCIENCE (2009)
Dexamethasone, Cerebrospinal Fluid Matrix Metalloproteinase Concentrations and Clinical Outcomes in Tuberculous Meningitis
Justin A. Green et al.
PLOS ONE (2009)
Monocyte-astrocyte networks regulate matrix metalloproteinase gene expression and secretion in central nervous system tuberculosis in vitro and in vivo
James E. Harris et al.
JOURNAL OF IMMUNOLOGY (2007)
Metalloproteinases: Mediators of pathology and regeneration in the CNS
VW Yong
NATURE REVIEWS NEUROSCIENCE (2005)
Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis
KY Lee et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo
NM Price et al.
JOURNAL OF IMMUNOLOGY (2001)
Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis
E Matsuura et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)
Share Paper
